$599

Wave Ph2 WVE-007 + Tirzepatide Combination Study; Abbott Partners with Berry Street for Nutrition Insights with Lingo

Two cardiometabolic-related news items have been observed: Wave Life Sciences initiated the Ph2a WVE-007 + tirzepatide combination arm of the INLIGHT study (view press release), and Abbott entered into a partnership with Berry Street for personalized nutrition insights with Lingo (view press release). Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Already a member? Log in here